Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients

Clinical Neuropharmacology

Volumn 19, Issue 4, 1996, Pages 305-313

  Poyurovsky, Michael ^a   Hermesh, Haggai ^b,c   Weizman, Abraham ^b,c  

^a Shaar Menashe Psychiat Hosp H   (Israel)

^b GEHA MENTAL HEALTH CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Clozapine; Fluvoxamine; Reuptake inhibitor; Schizophrenia; Serotonin

Indexed keywords

CLOZAPINE; FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CONSTIPATION; HUMAN; HYPERSALIVATION; MALE; OBSESSION; PRIORITY JOURNAL; SCHIZOPHRENIA; SOMNOLENCE; SYMPTOMATOLOGY; TACHYCARDIA;

EID: 0029927063     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199619040-00003     Document Type: Article

References (26)

1. Fenton WS, McGlashan TA. The prognostic significance of obsessive compulsive symptoms in schizophrenia. Am J Psychiatry 1986;143:437-41.
2. Siris SG. Adjunctive medication in the maintenance treatment of schizophrenia and its conceptual implications. Br J Psychiatry 1993;163(suppl 22):66-78.
3. Rosen I. Clinical significance of obsessions in schizophrenia. J Ment Sci 1957;103:778-85.
4. Insel TR. Obsessive-compulsive disorder: five clinical questions and a suggested approach. Compr Psychiatry 1982;23:241-51.
5. Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology (Berl) 1989;99(suppl):18-27.
6. Murphy DL, Zohar J, Benkelfat C, et al. Obsessive compulsive disorder as a 5-HT subsystem-related behavioral disorder. Br J Psychiatry 1984;155(suppl 8):15-24.
7. Goodman WK, McDougle CJ, Price LH, et al. Beyond the serotonin hypothesis: a role for dopamine in some forms of obsessive-compulsive disorder. J Clin Psychiatry 1990;51(suppl):36-41.
8. Patil VJ. Development of transient obsessive compulsive symptoms during treatment with clozapine [Letter]. Am J Psychiatry 1992;149:272.
9. Baker RW, Chengappa KNR, Baird JW, et al. Emergence of obsessive compulsive symptoms during treatment with clozapine. J Clin Psychiatry 1992;53:439-42.
10. Cassady SL, Thaker GK. Addition of fluoxetine to clozapine [Letter]. Am J Psychiatry 1992;149:1274.
11. Steingard S, Chengappa KNR, Baker RW. Clozapine, obsessive symptoms and serotonergic mechanisms [Letter]. Am J Psychiatry 1993;150:1435.
12. Patel B, Tandon R. Development of obsessive-compulsive symptoms during clozapine treatment [Letter]. Am J Psychiatry 1993;150:836.
13. Eales MJ, Layeni AO. Exacerbation of obsessive compulsive symptoms associated with clozapine. Br J Psychiatry 1994;164:687-8.
14. Mozes T, Toren P, Chernauzan N, et al. Clozapine treatment in very early onset schizophrenia. J Am Acad Child Adolesc Psychiatry 1994;33:65-70.
15. Allen L, Tejera C. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline [Letter]. Am J Psychiatry 1994;151:1096-7.
16. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812.
17. Goodman WI, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, I: development, use and reliability. Arch Gen Psychiatry 1989;46:1006-11.
18. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, IA: University of Iowa, 1983.
19. Young CR, Bostic JQ, McDonald CL. Clozapine and refractory obsessive-compulsive disorder: a case report [Letter]. J Clin Psychopharmacol 1994;14:209-11.
20. LaHoste GJ, O'Dell SJ, Widmark CB, et al. Differential changes in dopamine and serotonin receptors induced by clozapine and haloperidol. In: Tamminga CA, Schultz SC, eds. Advances in neuropsychiatry and psychopharmacology. Vol 1. New York: Raven Press, 1991:351-61.
21. Dursun SM, Reveley MA. Obsessive-compulsive symptoms and clozapine [Letter]. Br J Psychiatry 1994;165:267-8.
22. Coward DM. General pharmacology of clozapine. Br J Psychiatry 1992;160(suppl 17):5-11.
23. Goff DC, Brotman AW, Waites M, et al. Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients. Am J Psychiatry 1990;147:492-4.
24. Bacher NM, Ruskin P. Addition of fluoxetine to treatment of schizophrenic patients [Letter]. Am J Psychiatry 1991;148:274-5.
25. Silver H, Nassar A. Fluvoxamine improves negative symptoms in treated chronic schizophrenia. An add-on double-blind placebo-controlled study. Br Psychiatry 1992;31:698-704.
26. Zohar J, Kaplan Z, Benjamin J. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients. J Clin Psychiatry 1993;54:385-8.